Table 4.

Established cardiovascular and kidney disease in the additional risk assessment of hypertensives.

• Cerebrovascular disease

○ Ischemic stroke

○ Cerebral hemorrhage

○ Transient ischemic attack

• Coronary artery disease

○ Stable or unstable angina

○ Myocardial infarction

○ Myocardial revascularization: percutaneous (angioplasty) or surgical

○ Heart failure with reduced or preserved ejection fraction

○ Symptomatic peripheral arterial disease of lower limbs

○ Stage 4 chronic kidney disease (GFR < 30 mL/min/1.73m2) or albuminuria > 300 mg/24h

○ Advanced retinopathy: hemorrhages, exudates, papilledema

GFR: estimated glomerular filtration rate.